A number of genital cancer biopsy samples were screened for the presence of human papillomavirus type 16 (HPV-16) DNA sequences. One of these samples (a vulvar carcinoma in situ) was found to contain more than 100 copies of HPV-16 DNA sequences per cell. Using this tumour DNA, a genomic library was constructed in bacteriophage lambda and the library was screened for recombinant phage containing HPV-16 sequences. Five recombinant phage clones were isolated and their DNA was analysed by restriction endonuclease digestion and blot hybridization. All five recombinants contained two copies of the HPV-16 genome present in a head-to-tail arrangement. The data are consistent with the presence of HPV-16 sequences in the tumour DNA arranged as genomic dimers in a circular episomal configuration. The HPV-16 genomes contained a deletion within the non-coding region, a region which includes the viral origin of DNA replication and transcriptional control sequences. Possible consequences of this deletion for viral replication and transcription are discussed.
INTRODUCTION
Papillomaviruses induce benign papillomas or warts in man (Rowson & Mahy, 1967) and in a variety of animals (Lancaster & Olson, 1982) . The human papillomaviruses (HPVs) are an extremely diverse group comprising more than 30 distinct types (Gissmann & Schwartz, 1985) ; they contain a circular double-stranded DNA genome of approximately 8 kb (DeLap et al., 1977) .
Evidence strongly suggests that certain types of HPV are closely associated with specific human cancers; for example, epidermal cancer in patients with epidermodysplasia verruciformis is associated with HPV types 5 and 8 (Lutzner et al., 1984) . More recently, the proposal that HPVs are implicated in human genital cancer has been strengthened by detection of specific types in a high percentage of genital cancer biopsies (Diirst et al., 1983; Boshart et al., 1984; Scholl et al., 1985; Di Luca et at., 1986; Macnab et al., 1986) .
We have detected HPV-16 and HPV-18 DNA sequences in genital cancer biopsies from patients in the west of Scotland and north-east of England (Macnab et al., 1986) . Here, we describe the molecular cloning of HPV-16 DNA sequences from one of these biopsies (a vulvar carcinoma in situ) and present evidence for a head-to-tail tandem arrangement of HPV-16 genomes. Our data provide evidence for HPV-16 dimers present as circular episomal elements in the tumour DNA. We demonstrate that these HPV-16 genomes contain a deletion within the non-coding region (NCR) located between the early and late transcribed regions.
METHODS

DNA, bacteriophage and bacterial stocks.
The bacteriophage lambda vector EMBL3 and Escherichia coti strains K803, NM538 and NM539 (Frischauf et al., 1983) were kindly provided by Dr D. P. Leader. Human 0000-7385 t~ 1987 SGM I. M. KENNEDY AND OTHERS papillomavirus prototype genomes , cloned into pBR322, were provided by Drs H. zur Hausen and L. Gissmann. For use as DNA probes, prototype HPV DNAs were cleaved with the appropriate restriction endonucleases and separated from pBR322 sequences by two consecutive rounds of electrophoresis through low melting point agarose.
Isolation ofgenomic DNAfrom tumour biopsies. Tumour biopsies were surgically removed by Dr S. Walkinshaw as previously described (Macnab et al., 1986) ; the tumour biopsies described here were isolated from Caucasian women indigenous to the west of Scotland. Tumour DNA was prepared from tissue confined to malignant or histologically abnormal regions. Genomic DNA was extracted from biopsy samples in 0.4~ SDS, 50 mM-Tris-HC1 pH 8.0, 10 mM-EDTA, 0-1 M-NaC1 containing proteinase K (200 ~ag/ml) and phenol-extracted (Varmus & Bishop, 1973) , digested with RNase A (100 pg]ml) and re-extracted sequentially with phenol and chloroform. The DNA was dialysed extensively against 0.1 × SSC (1 x SSC is 0.15 M-NaCI, 15 raM-sodium citrate, pH 7), precipitated with ethanol and resuspended in H20.
Restriction endonuclease digestion and agarose gel electrophoresis. DNA was digested with appropriate restriction endonucleases (obtained from Gibco/Bethesda Research Laboratories) under conditions recommended by the supplier. Samples were analysed by electrophoresis in horizontal agarose slab gels in a buffer containing 36 mMTris pH 7"8, 30 mM-NaHzPO4, 1 mM-EDTA. Following electrophoresis, DNA was transferred to nitrocellulose membranes (Schleicher & Schfill BA85) or Gene Screen Plus membranes (New England Nuclear) as described by Southern (1975) and hybridized with radiolabelled HPV-16 DNA as outlined below or under conditions previously described (Macnab et al., 1986) .
Construction and screening of genomic DNA library. Genomic DNA was partially digested with Sau3AI, treated with phosphatase and ligated with the lambda vector EMBL3 which had previously been digested with BamHI and EcoRI essentially as described by Frischauf et al. (1983) . The in vitro packaging, phage amplification and propagation steps were carried out using standard procedures (Sternberg et al., 1977; Maniatis et al., 1982) . A library of 106 recombinant phage (approximately 1 genome equivalent of cellular DN A) was screened for HPV-16 DNA sequences and positive phage were isolated by standard procedures (Benton & Davis, 1977; Maniatis et al., 1982) . For hybridizations, cloned HPV DNA was cleaved and separated from pBR322 sequences as described above, prior to labelling with [~-3zp]dATP and [~-3Ep]dTTP by nick translation to a specific activity of approximately 108 c.p.m./~tg (Rigby et al., 1977) . The filter membranes were prehybridized at 65 °C in 5 x SSPE (1 x SSPE is 0.18 M-NaC1, 10 mM-NaHzPO4 pH 7.4, 1 mM-EDTA), 5 × Denhardt's solution (1 × is 0.02~ Ficoll 400, 0.02 % polyvinylpyrrolidone, 0.02 ~ bovine serum albumin), 0.1 ~ SDS and 100 ~tg/ml denatured calf thymus DNA. The hybridization mixture contained radiolabelled HPV-16 DNA (10 6 c.p.m./ml hybridization solution, 0.1 ml hybridization solution/cm 2 filter area). After incubation at 65 °C for 1 to 3 days, the filters were washed three or four times for 10 min in 2 x SSC, 0.1 ~ SDS followed by two washes in 1 × SSC, 0.1 ~ SDS at 65 °C for 1 to 2 h, air-dried and exposed to Kodak XAR-5 films. In digests involving DNA from phage clones, insert sequences were released from vector sequences by digestion with SalI before further digestion with other restriction endonucleases. The SalI site is located immediately adjacent to the Sau3AI/BamHI site on the vector polylinker sequence (Frischauf et al., 1983) .
RESULTS
Genomic DNA was isolated from a variety of genital tumour biopsies and samples (20 ~tg) were digested with endonuclease BamHI which cleaves HPV-16 DNA at a unique site (Dfirst et al., 1983) , subjected to agarose gel electrophoresis, transferred to Gene Screen Plus membranes and hybridized with radiolabelled HPV-16 DNA. The copy number of HPV-16 DNA in the tumour DNAs was estimated by comparing the tumour DNA hybridization to that obtained with known standard amounts of HPV-16 DNA (Fig. 1, lanes 1 and 2) . The vulvar carcinoma (Vu27; Fig. 1 Five recombinant phage clones were isolated and their D N A s analysed by restriction endonuclease digestion and blot hybridization. Results for all five recombinants were essentially the same; indeed, three clones appeared identical and may have been siblings derived from the amplification step. Therefore, analysis of a single representative clone (2HPV-16.1) is presented to illustrate the structure. A summary of the restriction maps of all the clones is included. expected to contain cleavage sites for at least one of the three additional enzymes, thus resulting in HPV-16-containing fragments with altered electrophoretic mobility. Results for clone 2HPV-16.1 (Fig. 3: compare lanes 1 and 2) show that the same three bands (sizes 7.9 kb, 6.9 kb and 1.05 kb) were present in single and multiple digests indicating that all three bands contained HPV-16 sequences and strongly suggesting that no cellular DNA was present. In addition, the sizes of the 2HPV-16.1 BamHI DNA fragments added up to approximately 16 kb, the size of the insert which could be detected as undigested DNA in Fig. 3 , lanes 1 and 2. The structures of the DNA clones were further analysed by digestion with other HPV-16 single cut restriction endonuclease (TaqI and HincII) either singly or in a double digest with BamHI and then comparing the hybridization patterns with the appropriate double digests generated with HPV-16 prototype DNA (Fig. 3, lanes 3 to 8) . Clone 2HPV-16.1 digested with TaqI produced three bands of 7.9 kb, 4.6 kb and 3-35 kb that hybridized to HPV-16 (Fig. 3, 4) and three bands of 7.9 kb, 6.1 kb and 1.95 kb with HincII (Fig. 3, lane 7) . The 7.9 kb band, observed with all three single cut enzymes, was likely to have been full-length HPV-16 D N A and hence the two smaller bands represented flanking partial copies of the HPV-16 genome. This structure was confirmed by the double digests (Fig. 3, lanes 3 and 6) which produced only I. M, KENNEDY AND OTHERS four bands of which two (5.6 kb and 2.3 kb with TaqI/BamHI; 5.0kb and 3.0kb with HincII/BamHI) corresponded to similar bands present in the appropriate double digests of HPV-16 genomic DNA; each of the other two bands was present in the appropriate single digests.
As the BamHI and HincII sites on the HPV-16 genome are 5 kb apart (Fig. 4b; Seedorfet al., 1985) , there must be at least 13 kb (approximately 1.6 genome equivalents) of HPV-16 DNA present in a head-to-tail orientation to produce full-length HPV-16 DNA when digested with these enzymes. Thus, it is probable that all 16 kb of the 2HPV-16.1 insert DNA (two genome equivalents) was HPV-16 DNA arranged in a head-to-tail configuration. From the mapping data (and similar data for the other HPV-16-containing clones) we were able to construct detailed restriction maps for all five clones (Fig. 4a) . These maps are consistent with additional data obtained by digestion of the clones with other enzymes for which the cleavage sites are shown in Fig. 4(b) .
As noted earlier ( (Fig. 4b ) and nucleotide sequence of HPV-16 (Seedorf et al., 1985) the deletion was localized to a 1 kb region (shown in Fig. 4b ) which spans the NCR of the HPV-16 genome. This NCR contains the origin of DNA replication and transcriptional control sequences. The PstI b fragment from clone J.HPV-16.1 has been subcloned into a pUC13 plasmid vector. Fine mapping and sequencing data (unpublished observations) indicate that the deletion extends for 121 bp from the G residue at position 7277 (or T residue at position 7278) to the T residue at position 7400 (or G residue at position 7401) in the numbering system according to Seedorf et al. (1985) . This confirms that the deletion is localized within the NCR and does not extend into the 3' end of the L1 open reading frame.
DISCUSSION
In the present study, we have shown that HPV-16 DNA sequences isolated from a vulvar carcinoma in situ are present in a head-to-tail tandem arrangement. As the sizes of the cloned inserts are approximately 16 kb and the size of HPV-16 prototype DNA is 7904 bp (Seedorf et al., 1985) this implies that there may be exactly two genomes of HPV-16 present in the clones. Moreover, for each clone the Sau3AI sites located at both ends of the cloned inserts appear to be identical and the three non-identical clones show selection of a different Sau3AI cloning site (Fig. 4a) . Inserts having this structure are unlikely to have been produced from an integrated tandem array of HPV-16 genomes as this would require two Sau3AI cuts at identical positions on two HPV-16 genomes separated by 16 kb (e.g. in genomes I and III Fig. 6b ). The probability of this occurring depends on the number of other Sau3AI sites present within 15 to 20 kb of the first Sau3AI cut (this length of 15 to 20 kb is the average size distribution of the tumour DNA used in cloning following partial digestion with Sau3AI). For the 2HPV-16.1 insert the number of such Sau3AI sites is 10 and the probability is therefore 1/10 or 0-1. For the inserts AHPV-16.2, 3, 4 and 5 the number of Sau3AI sites is eight and the probability is 1/8 or 0.125. The combined probability of all three inserts being 16 kb with identical ends is the product of the individual probabilities i.e. 1/640 or 0.00156. A much more likely event resulting in the generation of the cloned inserts is a single Sau3AI cleavage of a dimeric episomal arrangement of HPV-16 genomes (Fig. 6a) . Such a cleavage at any one of the 22 available Sau3AI sites in this arrangement will always produce inserts of 16 kb with identical ends, with a resulting probability of 1.0. For each insert arrangement there is a choice of two possible cleavage sites in the dimer (see Fig. 6a ).
It is well established that papillomavirus genomes are present in transformed and turnout cells as autonomously replicating episomal structures (Amtmann et al., 1980; Law et al., 1981; (a) 2HPV - Lancaster, 1981 ; Moar et al., 1981 ; Campo & Spandidos, 1983; Groffet al., 1983) . In these cases, the papillomavirus genomes generally were present as episomal monomers although Law et al. (1981) , Lancaster (1981) and Groff et al. (1983) described a fraction which may represent concatemeric forms. Binetruy et al. (1982) transformed rodent cells with bovine papillomavirus type l (BPV-1) linked to plasmids pBR322 or pML2; both virus and plasmid sequences were maintained as non-integrated molecules, predominantly as oligomeric forms in head-to-tail arrangement. Further, Waldeck et al. (1984) found by electron microscopy that BPV-1 genomes in transformed hamster cells were present as monomeric and dimeric episomes at nearly equal frequency. In studies of other circular DNA molecules which replicate autonomously such as mitochondrial DNA (Hudson & Vinograd, 1969) , polyoma virus (Cuzin et al., 1970) and simian virus 40 (SV40) (Jaenisch & Levine, 1971) , oligomeric circular molecules have been observed; the oligomeric SV40 DNA was infectious. In recent work with HPVs (D/irst et al., 1985; Boshart et at., t984) HPV-16 and HPV-18 DNAs have been detected in genital cancer biopsies as oligomeric episomes (analogous to the structures detected here), as monomeric episomes and as sequences integrated into the host genome. The evidence for oligomeric episomes was obtained from CsC1 centrifugation or twodimensional gel electrophoresis. Here, we present direct evidence for the existence ofoligomeric molecules in human genital tumours by molecular cloning of putative dimeric episomal structures from tumour DNA.
Although only dimeric HPV-16 genomes were isolated in this study, the presence in the tumour DNA of integrated sequences, and/or monomeric or higher oligomeric extrachromosomal structures is not excluded. Indeed, these structures are less likely to be observed here due to the partial Sau3AI cleavage employed during cloning and to the insert size optimum (10 to 20 kb) of the cloning vector.
The observation that the HPV-16 molecules characterized contain deletions is not particularly unusual. Deletions in papillomavirus isolates have been observed by others (Amtmann et al., I.M. KENNEDY AND OTHERS 1980; Ostow et al., 1982; Binetruy et al., 1982; Schwartz eta/., 1985) . However, these deletions were mainly in the late region which is not usually transcribed in transformed and tumour cells (Amtmann & Sauer, 1982; Heilman et at., 1982) and none have been described within the NCR which contains the origin of viral DNA replication and early gene transcriptional control signals.
HPV-6 isolates have been obtained from an invasive vulvar carcinoma (Rando et al., 1986 ) and a Buschke-L6wenstein tumour (Boshart & zur Hausen, 1986) which contain viral NCR sequence duplications. In one case (Rando eta/., 1986) , there was also evidence of insertions within the NCR of DNA with homology to cellular sequences. The nucleotide sequence for HPV-33 (Cole & Streeck, 1986) , isolated from a cervical carcinoma (Beaudenon eta/., 1986 ) also reveals tandem repeats of NCR sequences; these observations may be consistent with viral sequence duplications within the SV40 and polyoma virus enhancer and Moloney murine sarcoma virus long terminal repeat regions (Benoist & Chambon, 1981; Ruley & Fried, 1983; Dhar et al., 1980) . Studies with the human BK papovavirus (BKV) have shown that a plaque morphology mutant contains deletions and rearrangements of DNA within the viral NCR, near the origin of replication, and this virus exhibited increased transforming ability as compared to wild-type BKV (Watanabe & Yoshike, 1982; Watanabe et al., 1984a) . The increased transforming ability of the mutant has been ascribed to its capacity to express early viral functions constitutively (Watanabe et at., 1984b) .
Alterations within the HPV-16 NCR could affect the ability to replicate and/or express viral genes in tumour cells. The virus that originally infected the cells may have contained the deletion or the deletion may have been generated in the course of viral DNA persistence in the cells. The deletion is unlikely to be responsible for the production of oligomeric molecules since these appear to be a product of the replication of circular genomes which do not have alterations within the NCR. One possibility is that the deletion may affect the frequency of molecules in the tumour cells; the HPV-16 copy number was greater than 100. There is no direct evidence to sugggest that the dimeric molecules are replication-competent, although as we have obtained several clones this may suggest a relatively high abundance. We thank Professor J. H. Subak-Sharpe for his continuing interest, Dr S. Walkinshaw for providing tumour biopsies and Dr R. Thompson for reading the manuscript. Thanks to Ms F. Conway and Mrs J. Mavor for secretarial assistance. This work was supported by Cancer Research Campaign grant SP1341.
